✦ LIBER ✦
Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule
✍ Scribed by Heidi Hörig; David S. Lee; William Conkright; Joe Divito; Henry Hasson; Michelle LaMare; Audrey Rivera; David Park; John Tine; Ken Guito; Kwong Wong-Yok Tsang; Jeffrey Schlom; Howard L. Kaufman
- Publisher
- Springer-Verlag
- Year
- 2000
- Tongue
- English
- Weight
- 184 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.